摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diphosphorus pentasulfide | 952005-45-7

中文名称
——
中文别名
——
英文名称
diphosphorus pentasulfide
英文别名
phosphorus pentasulfide;phosphorous pentasulfide;phosphorous pentasulphide;phosphorous(V) sulfide;phosphorus (V) sulfide;Phosphorus(V) sulfide
diphosphorus pentasulfide化学式
CAS
952005-45-7
化学式
P2S5
mdl
——
分子量
222.278
InChiKey
HWVAJUNEPOKXLF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    154
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    diphosphorus pentasulfide1,2-tetramethylene-4-(4-chloro-3-isopropoxycarbonylphenyl)thiourazol5,5-dimethyl-1,3-cyclohexadiene 为溶剂, 以40%的产率得到1,2-tetramethylene-4-(4-chloro-3-isopropoxycarbonylphenyl)dithiourazol
    参考文献:
    名称:
    1H[1,2,4]-Triazolo[1,2-a]pyridazine-1,3-diones useful as herbicides
    摘要:
    一种化合物的分子式为:##STR1## 其中Z为##STR2## 其中R.sub.4为较低的烷基,X和Y为氧或硫,n为3至6的整数,R.sub.1为氢或卤素,R.sub.2为卤素,R.sub.3为氢或C.sub.1 -C.sub.8 -烷基,可能带有较低的烷氧基;包含该化合物作为有效成分的除草剂组合物;使用该化合物杀灭杂草的方法;以及该化合物的生产方法,以下将披露。
    公开号:
    US04561880A1
  • 作为产物:
    描述:
    iron phosphide 在 iron sulfide 、 sulfur 作用下, 生成 diphosphorus pentasulfide
    参考文献:
    名称:
    Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: S: MVol.A3, 5.3.6, page 721 - 724
    摘要:
    DOI:
  • 作为试剂:
    描述:
    2-苯乙酰胺diphosphorus pentasulfide 、 potassium sulphide 、 乙醚 、 aluminium amalgam 、 、 xylene 作用下, 生成 哌替啶杂质
    参考文献:
    名称:
    Kindler, Justus Liebigs Annalen der Chemie, 1923, vol. 431, p. 213
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Diamine derivatives
    申请人:Ohta Toshiharu
    公开号:US20050020645A1
    公开(公告)日:2005-01-27
    A compound represented by the general formula (1): Q 1 -Q 2 -T 0 -N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 (1) wherein R 1 and R 2 are hydrogen atoms or the like; Q 1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q 2 is a single bond or the like; Q 3 is a group in which Q 5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T 0 and T 1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
    通用式(1)表示的化合物: Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4(1) 其中R1和R2是氢原子或类似物;Q1是饱和或不饱和的、5-或6-成员环烃基,可以被取代,或类似物;Q2是单键或类似物;Q3是一个基团,其中Q5是具有1至8个碳原子的烷基基团,或类似物;T0和T1是羰基团或类似物;其盐、溶剂合物或N-氧化物。 该化合物可用作预防和/或治疗脑梗死、脑栓塞、心肌梗死、心绞痛、肺梗死、肺栓塞、布尔格病、深静脉血栓形成、弥散性血管内凝血综合征、瓣膜或关节置换后的血栓形成、血管成形术后的血栓形成和再闭塞、全身性炎症反应综合征(SIRS)、多器官功能障碍综合征(MODS)、体外循环期间的血栓形成,或抽血时的血液凝结。
  • Carbapenem derivatives
    申请人:Meiji Seika Kaisha, Ltd.
    公开号:US06458780B1
    公开(公告)日:2002-10-01
    Disclosed is a novel carbapenem derivative having a substituted imidazo[5,1-b]thiazole group at the 2-position on the carbapenem ring have high anti-microbial activities against &bgr;-lactamase producing bacteria, MRSA, resistant-Pseudomonas aeruginosa, PRSP, enterococci, and influenza, and high stabilities to DHP-1. According to the present invention, there is provided a compound represented by the formula (I), or a pharmacologically acceptable salt thereof or an ester at the 3-position on the carbapenem ring thereof:
    公开了一种新的碳青霉烯衍生物,其在碳青霉烯环的2位置具有取代的咪唑[5,1-b]噻唑基团,对产生β-内酰胺酶的细菌、耐甲氧西林金黄色葡萄球菌(MRSA)、抗假单胞菌属铜绿假单胞菌、肺炎链球菌(PRSP)、肠球菌和流感具有高的抗菌活性,并对DHP-1具有高稳定性。根据本发明,提供了一种由公式(I)表示的化合物,或其药理上可接受的盐,或其碳青霉烯环上3位置的酯。
  • Pyrido[2,3-D]pyrimidine derivatives and pharmaceutical compositions
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US06136810A1
    公开(公告)日:2000-10-24
    This invention relates to compounds (I) or pharmaceutically acceptable salts thereof, having a function to inhibit type IV phosphodiesterase (PDE) ##STR1## [X: an oxygen atom or a sulfur atom, R.sup.1 : a lower alkyl group, a cycloalkyl-lower alkyl group or a cycloalkyl group, R.sup.2 : a hydrogen atom, a halogen atom, a lower alkyl group, a halogeno-lower alkyl group, a hydroxy-lower alkyl group, a mercapto-lower alkyl group, a lower alkoxy-lower alkyl group, a lower alkylthio-lower alkyl group, a lower alkanoyloxy-lower alkyl group, a lower alkanoylthio-lower alkyl group, a lower alkanoyl-lower alkyl group, a hydroxyimino-lower alkyl group, a lower alkoxyimino-lower alkyl group, a cycloalkyl group, an aryl group or a lower alkanoyl group, R.sup.3 : a hydrogen atom, a halogen atom or a lower alkyl group, R.sup.4 : a hydrogen atom or a lower alkyl group, R.sup.5 : a cycloalkyl group; a naphthyl group substituted; a five- or six-membered monocyclic hetero ring group having 1 to 4 hetero atoms selected from nitrogen atom, oxygen atom and sulfur atom; or a group represented by the formula ##STR2## amd F.sup.6 : a halogen atom, a lower alkyl group, a halogeno-lower alkyl group, a hydroxyl group, a lower alkoxy group, a cyano group or a nitro group].
    这项发明涉及化合物(I)或其药学上可接受的盐,具有抑制第IV型磷酸二酯酶(PDE)的功能。
  • Triazolo and derivatives as chemokine inhibitors
    申请人:Toray Industries, Inc.
    公开号:US06492364B1
    公开(公告)日:2002-12-10
    Novel triazolo derivatives represented by the following formula and pharmaceutically acceptable salts thereof, as well as chemokine inhibitors containing the same as an effective component. These are useful as therapeutic agents for allergic diseases such as bronchial asthma and atopic dermatitis; therapeutic agents for inflammatory diseases such as chronic rheumatoid arthritis; therapeutic agents for autoimmune diseases such as ulcerative colitis and nephritis; and as anti-AIDS drugs.
    由以下公式表示的新颖三唑衍生物及其药用盐,以及含有相同物质作为有效成分的趋化因子抑制剂。这些对于过敏疾病如支气管哮喘和特应性皮炎的治疗剂、慢性类风湿性关节炎等炎症性疾病的治疗剂、溃疡性结肠炎和肾炎等自身免疫疾病的治疗剂以及抗艾滋病药物都是有用的。
  • Fodder compositions
    申请人:Egis Gyogyszergyar
    公开号:US05221673A1
    公开(公告)日:1993-06-22
    This invention relates to fodder compositions, particularly feed additives, premixes and ready-for-use fodders, and a method for increasing weight-gain and improving fodder utilization of dimestic animals. The compositions according to the invention comprise as active ingredient a compound of the general formula (I), ##STR1## wherein R.sup.1 represents methoxy or hydrogen and R stands for methyl; or R and R.sup.1 each denotes hydrogen; or R.sup.1 stands for hydrogen and R represents ethyl. The compounds of the general formula (I) known from the literature exhibit useful weight-gain increasing and fodder-utilization improving effects and can be used in animal husbandry.
    这项发明涉及饲料组合物,特别是饲料添加剂、预混合饲料和即用饲料,以及一种用于增加家畜体重和改善饲料利用率的方法。根据该发明的组合物包括一种通式(I)的活性成分,其中R.sup.1代表甲氧基或氢,R代表甲基;或者R和R.sup.1分别表示氢;或者R.sup.1表示氢,R表示乙基。根据文献已知的通式(I)的化合物具有有用的增重和改善饲料利用效果,可用于畜牧业。
查看更多